These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1717529)

  • 1. Expression of OKM5 antigen on keratinocytes in some dermatoses.
    He C; Zhao Y; Chen HD
    J Dermatol; 1991 Apr; 18(4):196-200. PubMed ID: 1717529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD36 (OKM5) antigen on epidermal cells in normal and diseased skin.
    Juhlin L
    Acta Derm Venereol; 1989; 69(5):403-6. PubMed ID: 2572105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte expression of OKM5 antigen in inflammatory cutaneous disease.
    Barker JN; Markey AC; Allen MH; MacDonald DM
    Br J Dermatol; 1989 May; 120(5):613-8. PubMed ID: 2474314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of Langerhans cells and expression of class II antigens on keratinocytes in malignant and benign epithelial tumors of the skin: an immunohistopathologic study with monoclonal antibodies.
    Chen HD; Zhao YM; Sun G; Yang CY
    J Am Acad Dermatol; 1989 Jun; 20(6):1007-14. PubMed ID: 2474010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of monocyte/macrophage markers (CD13, CD14, CD68) on human keratinocytes in healthy and diseased skin.
    Hunyadi J; Simon M; Kenderessy AS; Dobozy A
    J Dermatol; 1993 Jun; 20(6):341-5. PubMed ID: 7688777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte and epidermal leukocyte expression of CD36 (OKM5) in benign and malignant skin diseases.
    Lisby S; Ralfkiaer E; Hansen ER; Vejlsgaard GL
    Acta Derm Venereol; 1990; 70(1):18-22. PubMed ID: 1689091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.
    Hansen ER; Baadsgaard O; Lisby S; Cooper KD; Thomsen K; Vejlsgaard GL
    J Invest Dermatol; 1990 Apr; 94(4):485-91. PubMed ID: 1968933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanophages in inflammatory skin disease demonstrate the surface phenotype of OKM5+ antigen-presenting cells and activated macrophages.
    Weiss JS; James WD; Cooper KD
    J Am Acad Dermatol; 1988 Oct; 19(4):633-41. PubMed ID: 2460508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic distribution of staining by a monoclonal antibody (psi-3) in psoriasis and occurrence of psi-3 antigen in other cutaneous diseases.
    Strefling AM; Knapp AM; Mansbridge JN
    J Invest Dermatol; 1985 Feb; 84(2):100-4. PubMed ID: 2578527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the myelomonocytic antigens L1 and CD36 in human epidermis.
    Barker JN; Allen MH; Griffiths CE; Nickoloff BJ; MacDonald DM
    Br J Dermatol; 1990 Oct; 123(4):548-9. PubMed ID: 1710139
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of OKM5 antigen on epidermal cells in mycosis fungoides plaque stage.
    Lisby S; Baadsgaard O; Cooper KD; Thomsen K; Wantzin GR
    J Invest Dermatol; 1988 May; 90(5):716-9. PubMed ID: 2452212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte expression of CD36 antigen in benign and malignant epidermal cell-derived tumours.
    Allen MH; Barker JN; MacDonald DM
    J Cutan Pathol; 1991 Jun; 18(3):198-203. PubMed ID: 1717527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of complement receptor CR2 (CD21) on human subcorneal keratinocytes in normal and diseased skin.
    Hunyadi J; Simon M; Kenderessy AS; Dobozy A
    Dermatologica; 1991; 183(3):184-6. PubMed ID: 1835941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased numbers of CD68 antigen positive dendritic epidermal cells and upregulation of CLA (cutaneous lymphocyte-associated antigen) expression on these cells in various skin diseases.
    Nakamura K; Yasaka N; Asahina A; Kato M; Miyazono K; Furue M; Tamaki K
    J Dermatol Sci; 1998 Dec; 18(3):170-80. PubMed ID: 9865449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of OKM5 antigen on human keratinocytes in positive intracutaneous tests for delayed-type hypersensitivity.
    Simon M; Hunyadi J
    Dermatologica; 1987; 175(3):121-5. PubMed ID: 2443399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective expression of immune-associated surface antigens by keratinocytes in irritant contact dermatitis.
    Willis CM; Stephens CJ; Wilkinson JD
    J Invest Dermatol; 1991 Apr; 96(4):505-11. PubMed ID: 1706746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen and related antigens expressed on keratinocytes in inflammatory dermatoses.
    Egawa K; Honda Y; Kuroki M; Inaba Y; Ono T
    Br J Dermatol; 1996 Mar; 134(3):451-9. PubMed ID: 8731668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesional keratinocytes express OKM5, Leu-8 and Leu-11b antigens in lichen planus.
    Simon M
    Dermatologica; 1988; 177(3):152-8. PubMed ID: 2458976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of immune associated surface antigens of keratinocytes in human papillomavirus-derived lesions.
    Viac J; Soler C; Chardonnet Y; Euvrard S; Schmitt D
    Immunobiology; 1993 Aug; 188(4-5):392-402. PubMed ID: 7503944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR-antigen bearing keratinocytes in various dermatologic disorders.
    Smolle J
    Acta Derm Venereol; 1985; 65(1):9-13. PubMed ID: 2578718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.